The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
94991028 9499102 8 F 20160804 20160914 20130904 20160921 EXP CA-ROCHE-1269734 ROCHE 62.59 YR F Y 0.00000 20160921 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
94991028 9499102 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous 375 MG, BIW U S0003C 103976 375 MG SOLUTION FOR INJECTION QOW
94991028 9499102 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous 375 MG, BIW U S0003C 103976 375 MG SOLUTION FOR INJECTION QOW
94991028 9499102 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0003C 103976 SOLUTION FOR INJECTION
94991028 9499102 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0003C 103976 SOLUTION FOR INJECTION
94991028 9499102 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0003C 103976 SOLUTION FOR INJECTION
94991028 9499102 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0003C 103976 SOLUTION FOR INJECTION
94991028 9499102 7 C NASACORT TRIAMCINOLONE ACETONIDE 1 Unknown UNK U 0
94991028 9499102 8 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Respiratory (inhalation) 2 DF,(2 PUFF) BID U 0 2 DF BID
94991028 9499102 9 C VENTOLIN ALBUTEROL SULFATE 1 Unknown 2 DF, (2 PUFF) U 0 2 DF
94991028 9499102 10 C PREDNISONE. PREDNISONE 1 Unknown Y 0
94991028 9499102 11 C FLOVENT FLUTICASONE PROPIONATE 1 Unknown 0.05 MG, QD U 0 .05 MG QD
94991028 9499102 12 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown 18 UG, QD U 0 18 UG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
94991028 9499102 1 Asthma
94991028 9499102 7 Product used for unknown indication
94991028 9499102 8 Product used for unknown indication
94991028 9499102 9 Product used for unknown indication
94991028 9499102 10 Adrenal insufficiency
94991028 9499102 11 Product used for unknown indication
94991028 9499102 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
94991028 9499102 HO
94991028 9499102 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
94991028 9499102 Addison's disease
94991028 9499102 Adrenal insufficiency
94991028 9499102 Blood pressure decreased
94991028 9499102 Headache
94991028 9499102 Hypokinesia
94991028 9499102 Influenza
94991028 9499102 Lung infection
94991028 9499102 Malaise
94991028 9499102 Nasopharyngitis
94991028 9499102 Respiratory rate decreased
94991028 9499102 Syncope

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
94991028 9499102 1 20110204 201302 0
94991028 9499102 2 20130828 20130828 0
94991028 9499102 3 20160721 0
94991028 9499102 4 20160804 0
94991028 9499102 5 20160831 0
94991028 9499102 6 20160914 0